Stepan R&D Spending Growth & History (SCL)
Stepan's r&d spending was $34.8M for fiscal 2025.
View full Stepan company overviewStepan annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $34.8M | $1.3M | +3.74% |
| 2024 | 2024-12-31 | $33.5M | −$2.2M | −6.12% |
| 2023 | 2023-12-31 | $35.7M | −$5.2M | −12.64% |
| 2022 | 2022-12-31 | $40.9M | $2.1M | +5.48% |
| 2021 | 2021-12-31 | $38.8M | $2.8M | +7.72% |
| 2020 | 2020-12-31 | $36.0M | $1.9M | +5.45% |
| 2019 | 2019-12-31 | $34.1M | $620,000 | +1.85% |
| 2018 | 2018-12-31 | $33.5M | $350,000 | +1.06% |
| 2017 | 2017-12-31 | $33.2M | −$1.7M | −4.84% |
| 2016 | 2016-12-31 | $34.9M | $4.5M | +14.98% |
| 2015 | 2015-12-31 | $30.3M | $3.1M | +11.30% |
| 2014 | 2014-12-31 | $27.2M | −$1.5M | −5.37% |
| 2013 | 2013-12-31 | $28.8M | $750,000 | +2.68% |
| 2012 | 2012-12-31 | $28.0M | $2.9M | +11.56% |
| 2011 | 2011-12-31 | $25.1M | $910,000 | +3.76% |
| 2010 | 2010-12-31 | $24.2M | — | — |
Stepan quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $17.2M | $2.5M | +16.96% |
| Q1 2026 | 2026-03-31 | $15.0M | — | — |
| Q4 2025 | 2025-12-31 | $15.7M | — | — |
| Q3 2025 | 2025-09-30 | $14.2M | — | — |
| Q2 2025 | 2025-06-30 | $14.7M | — | — |
Stepan r&d spending trends
Over the last five fiscal years, Stepan's r&d spending decreased from $36.0M to $34.8M, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $17.2M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stepan source filings ↗